RE: Daytraders left the building!24 Feb 2025 12:47
@Icecool & @Ryan, I couldn't help but post, reading your rants both side of the pond. Couple of questions (FYI, I am a dip buyer btw last week, so hold a small punt)
1) Past account restatements have no impact on current cash statements, but has anyone considered if previous statements are revised, company may become in breach of covenants historically otherwise (in retrospect). How would lenders consider that? Any precedent? Surely company would have some form of liability based on that to lenders?
2) Debt refi's do not happen at the last minute (I am telling you as a professional with almost 2 decades of banking experience in IB), so Icecool your arguments are far from actual market practice. Has anyone considered that any refi this year may come at a higher cost than historical (given more distressful situation now with -ve cash flow vs before, and higher rates vs 3-5 years back). This would surely have more -ve impact on cash flows - more in 2026 than this year?
3) I have gone through historical results and management presentations - they have claimed since 2022 (you can see their investor presentation and subsequent ones) that the company will turn cash flow positive from 2024, which moved to 2025 and now to 2026. Beyond management's words (which have been repeatedly incorrect), what evidence does anyone have to say CF will be positive from 2026?
4) I can see a sense of raising a fresh equity via Rights issue (but it will be sizeable vs current cap) - see precedents of Capita, Asos, and more recently Synthomer. Ideally they should be raising it with their FY results in March, but they cant do that before completion of Deloitte's work, after that they would need at least a month or two to get prospectus done etc. If they are indeed to do a new rights issue, the earliest feasible is with their HY results at the most earliest, followed or concurrent with a debt refi deal. I am sure this is what their advisors will be advocating. However, no one is stopping the company from making an announcement or indicating a potential rights issue along with their FY results, unless clearly they have better visibility. This has pros and cons from company's perspective, but not recommended if the company is not sure.
5) Hostile takeover or activist shareholder - possible, but common sense say, its very unlikely before the completion of Deloitte's review. Also, if the company will do a rights issue, shares will depress further at that time, and makes more sense to wait for a better opportunity. Also, from a takeover perspective, there is relatively little value looking at market cap now, when the debt forms such a significant portion in the enterprise value.
I can go on and on further on several other topics, including seemingly cheap valuation - but I think this should be enough to stimulate thoughts. I am not trying to push the stock down, and these have been well covered in analyst reports btw. but keen to understand other genuine / unbiased perspect